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INTRODUCTION 1
In the recent years, locally advanced cervical cancer treatment has changed from single 2 radiation therapy [1] to concurrent chemo-radiotherapy, since the 1999 National Cancer Institute Alert 3 strongly supported its use in all patients with cancer requiring radiation, based on results of five large 4 randomized trial [2] [3] . Neoadjuvant chemotherapy followed by surgery is a completely different 5 therapeutic approach that seems to offer some specific advantages over chemoradiation, such as a 6 potential higher activity against micrometastastic disease, a debulking effect improving subsequent 7 surgical outcome, less toxicity, and an easier management of salvage therapy [4] . 8
Laparoscopic assisted vaginal radical hysterectomy and total laparoscopic radical hysterectomy 9 (TLRH), and, more recently, robotic surgery, have been performed in early stage cervical cancer, with 10 no adverse effect in patient's overall prognosis and survival [5] . This data has also been confirmed by 11 our recent experience [6] . The feasibility of this procedure in locally advanced cervical cancer, 12 especially in patients treated with neoadjuvant chemotherapy, has not been investigated. 13
The purpose of the present study was to evaluate the feasibility and morbidity of total laparoscopic 14 radical hysterectomy (type C 2 
Study design and data collection 2
Patients with histological confirmed locally advanced cervical carcinoma (International 3
Federation of Gynaecology and Obstetrics (FIGO) stages IB2-IIB) [8] were eligible for the study; from 4 October 2004 to September 2009 patients received 3 courses of neoadjuvant chemotherapy, and were 5 then evaluated under anaesthesia in combination with MRI, before and after chemotherapy. Further 6 eligibility criteria included: ECOG performance status of 2 or less, adequate bone marrow reserve 7 (absolute granulocyte count ≥2000/ml, platelet count ≥100 000/ml); and adequate renal, hepatic, and 8 cardiac function. Patients who showed clinical response to NACT were eligible for TLRH with pelvic 9 lymphadenectomy. Patients that were not considered candidates for the laparoscopic approach 10 underwent abdominal radical hysterectomy (ARH). Previous abdominal surgery was not considered a 11 contraindication for the laparoscopic approach. 12
Approval to conduct the study was obtained independently from an internal review board at each 13 participating institution. Informed consent, including to neoadjuvant chemotherapy, clinical evaluation 14 and laparoscopic surgery, was obtained from all patients in accordance with local and international 15 legislation (declaration of Helsinki). All the patients who underwent TLRH were informed that ARH 16 would be carried out if difficulties were encountered with the laparoscopic approach. 17 Surgery was performed at the department of surgical gynaecologic oncology of two Italian hospitals, 18 the San Gerardo Hospital, Monza (16 patients), and National Cancer Institute "Regina Elena" of Rome 19 (24 patients). Clinical patient characteristics including age, body mass index (BMI), clinical stage 20 according to FIGO, histopathologic subtype, and tumour grade were recorded. Intraoperative 21 parameters evaluation included complications, blood loss and haemoglobin (Hb) drop. Blood 22 transfusions were administrated if Hb value was ≤ 7 g/L. Postoperative parameters included short-term 23 (within 30 days of the procedure), and long-term complications (more than 30 days after the procedure); 24 moreover, status of the surgical margins, status and number of pelvic lymph nodes removed, length of 25 dissected vagina, width of bilateral parametrium were evaluated, along with pathological response 1 evaluation, length of hospitalization, time to recovery of normal bladder function, median follow-up 2 duration, recurrence, and disease-free interval (DFI). 3
Neoadjuvant chemotherapy and evaluation of clinical response 4
Neoadjuvant chemotherapy was chosen according to the regimen of the European study 5 SNAP01 [9] . Clinical objective tumour responses were evaluated according to the Response Evaluation 6
Criteria in Solid Tumours criteria [10] . Pathological responses were defined as follows: optimal 7 response (OPR) included complete pathologic response (PRC) with complete disappearance of tumour 8 in the cervix and negative nodes, or a residual disease with <3mm stromal invasion including in situ 9 carcinoma (pPR1); suboptimal response (SOR) consisted of persistent residual disease with >3 mm 10 stromal invasion on surgical specimen (pPR2). After clinical evaluation of response, before and after 11 NACT, all patients deemed operable underwent total laparoscopic radical hysterectomy (type C 2 ) with 12 pelvic lymphadenectomy within 4 weeks from the last chemotherapy cycle. 13
Women with positive nodes, parametrial involvement, cut-through or SOR or OPR but with positive 14 nodes underwent further treatment (chemotherapy, external beam irradiation plus brachytherapy or 15 chemoradiation). Patients with inoperable tumours because of lack of response, defined as <50% 16 decrease or <25% increase in the product of the two largest perpendicular diameters of the measurable 17 lesion, or patients progressive after neoadjuvant chemotherapy, defined as >25% increase in the 18 product of the two largest perpendicular diameters of one measurable lesion or the appearance of new 19 ones, were offered radiotherapy. 20
Surgical procedure and characteristics 21
No uterus manipulator devices were used, but the cervix were grasped with a tenaculum and a 22 medical grade silicone balloon, named colpo-pneumo occluder (Cooper Surgical) were emplaced in 23 vagina in order to preserve an adequate pneumoperitoneum during colpotomy. 24 6 The first step of our technique consist in opening the retroperitoneal spaces according to the following 1 sequence: paravescical space, pararectal lateral space (Latzko), pararectal medial space (Okabayashi), 2 rectovaginal space and vescicovaginal space. 3
The second step is the "en bloc" level 1 and level 2 pelvic lymphadenectomy according to Querleu and 4
Morrow classification [7] . Para-aortic lymphadenectomy is not routinely performed unless suspicious 5 pelvic lymph nodes are confirmed to have metastatic disease on frozen section evaluation in order to 6 determine the field of postoperative radiation. 7
Afterwards, type C2 radical hysterectomy is performed as described by Querleu and Morrow [7]. The 8 uterosacral ligment is isolated into two parts according to Yabuki [11] , the middle part and the lateral 9 part, which can be coagulated and then dissected by scissors, respectively from the shallow layer to the 10 deep layer close to the pelvic sidewall. The ureter is dissected free from the overlying uterine artery and 11 vesicouterine ligament using the curved tip of the gyrus shears and the anterior parametrium is 12 coagulated laterally so that the ureter can be completely unroofed to the point of insertion into the 13 bladder according to Tokyo technique [11] [12] . To prevent heat damage to the ureter, saline irrigation is 14 performed during Gyrus coagulation. Finally uterosacral ligament is transacted close to the rectum, 15 vescicouterine ligament close to the bladder. Paracervical tissue is also completely removed, including 16 the part caudal to the deep uterine vein. 17
In young patients whose ovarian function needs to be preserved, the ovaries are transposed laterally to 18 the para-colic gutters and fixed securely to the abdominal wall. 19
After a careful control of blood loss, to minimize the risk of port site metastases, the vagina and all the 20 ports sites are irrigated with 5% povidine-iodine solution before completion of the surgery. 21
In all patients the urine catheter is removed 3 days after operation and an intermittent self catheter is 22 used for voiding until the residual urine volume is less than 100 ml. 23 24 25 RESULTS 1
Patient characteristics (Table 1) 2
From October 2004 to September 2009, forty patients were included into the study. The median 3 age was 46 years (range 25 -65), median BMI was 24 kg/m 2 (range 15 -49 kg/m 2 ). Four patients 4 converted to laparotomy for the following reasons: one was found with a diaphragm hernia, one was 5 diagnosed as pneumoderma, one was found with a rupture of the uterus at the isthmus due to cancer 6 and the remaining patient was diagnosed with a bulky pelvic lymph node metastasis of about 1.5 cm of 7 diameter not evidenced by MRI and strongly adherent to the left iliac vein. A total of 36 patients 8 underwent total laparoscopic radical hysterectomy (type C 2 ) and pelvic lymphadenectomy. All patients 9
were evaluated for toxicity and response to chemotherapy. 10
Toxicity and response to chemotherapy 11
A total of 90 courses of chemotherapy were administered. Toxicity is shown in table 2. Thirty 12 seven out of 40 patients had good clinical response to NACT. The median diameter of tumour 13 evaluated before chemotherapy administration was 43 mm (range, 30 -70 mm), while it was 14 mm 14 (range, 0 -40 mm) after chemotherapy (evaluated under anesthesia and MRI) and 11mm (range, 0 -33 15 mm) by final pathological evaluation after surgery. Eighteen patients had an optimal response (pCR, 16 pPR1) to chemotherapy, 15 patients had a pPR2 and 3 patients showed no response with parametrial 17 invasion. 18
Perioperative parameters (Table 3) 19
Median ooperative time was 305 min (range, 215 -430) and it was strongly correlated with 20 patients BMI. In two patients with high BMI (49 and 43 kg/m 2 ), the operative time was longer than 400 21 min, and in 5 patients with BMI less than 25 kg/m 2 , the median operative time was 270 min (range, 22 215 -300). The median blood loss was 250 ml (range, 100 -400 ml); none of the patients required 23 intraoperative blood transfusion, while four patients had a postoperative blood transfusion. The median 24
Hb drop was 2 g/L (range, 0.3 -4.8 g/L) before and 24 hours after operation. 25 8 The median number of removed pelvic lymph nodes was 24 (range, 10 -64). Eight squamous cell 1 carcinoma and one adenocarcinoma patients had a total of 9 positive pelvic nodes at frozen section. In 2 these nine patients, lymphadenectomy was extended to the para-aortic nodes, with negative specimens. 3
The superior border of the dissection in the para-aortic lymphadenectomy was the inferior mesenteric 4 artery and the median number of removed para-aortic lymph nodes was 7 (range, 5 -11). 5
The median length of dissected vagina was 21 mm (range, 15 -45 mm). The median width of 6 parametrium was 30 mm on the right side (range, 15 -50 mm) and 30 mm on the left side (range, 15 -7 60). The surgical margins were free of disease in all cases. 8
There was 1 intraoperative complication: one patient had injury of the left hypogastric vein and 9 promptly repaired during the same laparoscopic surgery with a total blood loss of 300 ml without need 10 of blood transfusion. 11
Postoperative parameters 12
There were 2 postoperative short term complications: in one case postoperative pelvic bleeding 13 was successfully recovered by drainage; a second patient suffered from lymphocyst on the 10 th day 14 post-operation. 15
Long term complications were: bladder symptoms in 16 patients, reduction in bladder sensitivity in 8, 16 recurrent urinary tract infection in 2 and urinary incontinence in 6. Moreover one patient had a left 17 ureteral fistula that was diagnosed 3 month later by urography. This patient underwent placement of a 18 nephrostomy for 5 months and then an ureteral stent that was removed after 3 months with no sequelae. 19
Eleven patients had bowel symptoms: 9 constipation and 2 a reduction of sensitivity. Other 8 patients 20 had symptoms relating to vaginal and sexual function: 3 a reduction of sensitivity, 3 a vaginal pain 21 during sexual intercourse and 2 complaining of vaginal dryness. In contrast, 5 patients, of age less than 22 45 years who had kept their ovaries, had no change in sexual activity, except for one patient who 23 underwent further radiotherapy. Self catheterization was started on day 3 from the intervention. The 24 time to resumption of normal bladder function ranged from 10 days to 3 months. Four patients treated 25 with radiation therapy and three with chemoradiation plus brachytherapy showed a worsening in 1 condition. The median length of hospital stay was 6 days (range 3 -12 days). 2
Further management and long term follow up 3
Three patients with parametrial invasion underwent further adjuvant concomitant radio-4 chemotherapy. Nine patients with positive nodes underwent 3 further cycles of chemotherapy with TIP 5 regimen, and five patients received adjuvant radiation therapy due to the coexistence of 6 lymphovascular space involvement (LVSI). 7
The median follow-up was 37 months (range, 10 -69 months). Thirty-three patients are free from 8 recurrence at the time of this report. One patient, who had no pathological response with parametrial 9 invasion, suffered from a central pelvic recurrence, with a DFI of 9 months, and died of disease after 12 10 months. Another patient, who obtained a partial response, demonstrated pelvic lymph node 11 involvement after neoadjuvant chemotherapy, and treated with adjuvant chemotherapy, showed lung 12 metastasis, with a DFI of 19 months; she underwent removal of metastases and is currently disease free 13 after 56 months. Other two patients, who obtained a partial response, suffered from a pelvic lymph 14 node and lung plus liver recurrence, with a DFI of 5 and 22 months respectively. They underwent 15 chemotherapy and are currently alive with disease after 21 and 34 months respectively. From a recent report, in locally advanced stages cervical cancer, NACT followed by radical 2 hysterectomy showed an absolute benefit of 15% at 5-year survival [9]. Therefore we started the 3 present study with totally laparoscopic radical hysterectomy and lymphadenectomy after NACT based 4 on our previous experience of laparoscopic type III radical hysterectomy in early stage cervical cancer 5
[5]. 6
Response to neoadjuvant chemotherapy 7
We achieved a good clinical response after NACT by combined evaluation under anaesthesia 8 and MRI. Pathological evaluation showed 9 pCR, 9 pPR1 and 15 pPR2. Notwithstanding the combined 9 evaluation (anaesthesia and MRI) of the cervix size, three patients had no pathological response, with 10 the invasion of parametrium, and one of them had a recurrence after 9 months after the operation and 11 died of disease after 12 months. Therefore the importance of an accurate clinical evaluation after 12 NACT is mandatory. In our study the TIP regimen as NACT has been confirmed to be effective and 13 tolerable, as reported by other recent published trials [9, 13] . 14
Surgical procedure 15
Regarding the surgical procedure, we achieved 90% success rate of laparoscopic surgery with 16 only 4 conversions. There was no limitation of BMI (range, 15-49 kg/m 2 ). Using this technique, we 17 performed total laparoscopic radical hysterectomy in early stage cervical cancer [7], extended to the 18 locally advanced cervical cancer after NACT. To overcome the debate on the shortage of uterosacral 19 ligament and length of vagina resection, several modifications were made in the laparoscopic procedure 20 compared with laparotomy. 21
First we used the special colpo-pneumo occluder instead of uterus manipulator leading to a better 22 direction of the vagina and sufficient vaginal resection. 23
Moreover changing the order of dissection in the laparoscopic procedure lead to several advantages. In 24 fact, starting the dissection from the lateral parametrium resulted in significant uterus uplift, thus 25 making the dissection of the uterosacral ligament easier. In fact, the section of the lateral parametrial 1 just after the section of the upper part of the posterior pillar allows lifting up the lower part of the 2 posterior pillar leading to its better exposure. 3
The third characteristic of our procedure is the "en bloc" lymphadenectomy. The key point of this 4 procedure is to make an advanced separation of the paravescical and the pararectal space laterally and 5 medially, respectively, then remove pelvic lymph nodes around the vein, artery and nerves completely 6
including the common iliac node pushing the nodes laterally or medially until all the nodes are 7 removed together. So, we emphasize the step by step techniques. Never start the next procedure before 8 you complete the previous one. 9
Finally when all the lymph nodes were well separated, they can be moved in the 'En bloc' way. Using 10 this technique, an average of 24 lymph nodes were removed in both sides, and there were no significant 11 complications except in one patient with lymphocyst. 12
Median length of hospital stay was 6 days (range, 3 -12). The reason for this prolonged hospitalization 13 was due to postoperative short term complications that requires a total of 12 days of hospitalisations. 14 Indeed, without these three complications, the median hospital stay was 4 days (range, 3 -7). 15
Oncological results 16
No large series are available thus far to analyze the surgical and oncological results of this 17 approach. The effects of NACT on pelvic tissues are thought to increase the difficulties of surgical 18 dissection, in particular on pelvic structures such as the bladder and ureters. Due to these difficulties, 19 laparoscopic techniques are generally not used to perform radical hysterectomy after NACT. In our 20 study, we demonstrated the feasibility of a laparoscopic approach in this setting in 90% of the cases. 21
The low surgical difficulties of surgery on pretreated tissues were evidenced in our experience by the 22 low rate of conversion to laparotomy. Moreover, we showed that surgical outcomes were similar to 23 others reports on laparoscopic radical hysterectomy and pelvic lymphadenectomy in early cervical 24 cancer without NACT [14-29,6]. 25
Recently, Colombo et al. [30] has described the first experience of TLRH for locally advanced cervical 1 carcinoma after concurrent chemoradiation therapy in which he reviewed 102 patients treated 46 with 2 TLRH and 56 with ARH. In the laparoscopic group the intraoperative and postoperative complications 3 were 10.9% and 28.3% respectively, while incomplete resection, that was associated with microscopic 4 or macroscopic residual disease, in 8.7%. The OS and the DFS were 82% and 81% respectevely. 5
Although the two studies are hardly comparable, we had less intraoperative complications and free 6
surgical margins compared to this study, probably reflecting the different anatomical alterations 7 induced by chemoradiation. 8
In the present initial experience a radical excisions of paracervix has been performed in all cases 9 because in the letterature there is not agreement on which radicality should be done after neoadiuvant 10 treatment. After the present results, to reduce postoperative long-term complications, in our istitution 11 we start to use of nerve sparing laparoscopic radical hysterectomy (type C 1 ) in patients with locally 12 advanced cervical cancer after clinical complete response to neoadjuvant chemotherapy. 13
The status of the pelvic lymph nodes and response to neoadjuvant chemotherapy were found to be two 14 major prognostic factors in our cohort of 40 patients operated on after NACT. Disease-free and overall 15 survivals with low local and distant recurrence rates were higher for patients with complete histological 16 response or microscopic residual disease on histopathologic examination. For patients with partial 17 response with significant residual disease after NACT, survival was poor with a high risk of local and 18 systemic relapse. This identified subgroup of patients could be submitted to adjuvant therapies. 19
The present study indicates that totally laparoscopic radical hysterectomy can be performed not only in 20 early stage cervical cancer but also in locally advanced stage cervical cancer after neoadjuvant 21 chemotherapy; this technique is feasible and safe, with less blood loss and less intraoperative and 22 postoperative short term complications. The key point is to make an accurate evaluation and restaging 23 of the patients after neoadjuvant chemotherapy. 
